Startups
Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.
Overview
Location
United States, Massachusetts, Cambridge
Employees
51-200
Total raised
$109M
Founded date
2018
Investors 4
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| May 8, 2021 | Lux Capital Management | luxcapital.com |
| Sahsen Ventures | sahsen.com | |
| May 12, 2021 | GV | gv.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 11, 2020 | Seed round | $9M |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 28, 2025 | ZAKA VC Backs Nephrogen’s Kidney-Focused Gene Therapy Platform | ZAKA VC supports Nephrogen, a gene therapy startup for kidney and pancreas diseases The founder is motivated by personal health experience to develop a cure Nephrogen’s NeFIND™ platform enables precise, efficient, and scalable gene therapy ... |
| May 22, 2023 | Dyno Therapeutics Launches the Dyno bCap 1 Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence | – Dyno bCap 1 exhibits 100x improvement versus AAV9 in delivery to the central nervous system (CNS) and 10x detargeting of liver after intravenous (IV) dosing, as characterized across multiple non-human primate (NHP) species – – Compared he... |
| May 7, 2021 | Dyno Therapeutics gets $100M in a16z-led round | Dyno Therapeutics, a biotech startup that's applying AI to gene therapy, has announced a $100 million Series A led by Andreessen Horowitz, with participation from new investors including Casdin Capital, GV, Obvious Ventures and Lux Capital.... |
| May 6, 2021 | Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI‑powered Gene Therapy Platform | Dyno Therapeutics, Inc., a biotechnology company applying artificial intelligence (AI) to gene therapy, today announced a $100 million Series A financing led by Andreessen Horowitz, with participation from a select syndicate of new investor... |
| May 6, 2021 | Dyno grabs $100M to expand tech, build team, ink more gene therapy partnerships | Dyno Therapeutics emerged last year with a modest seed round and Big Pharma partnerships to fuel its work designing new and improved viral vectors to deliver gene therapy. Now, the company is kicking it up a notch with a $100 million financ... |
| May 6, 2021 | Dyno Therapeutics Closes $100M Series A Financing | Dyno Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company applying artificial intelligence (AI) to gene therapy, raised $100m in Series A financing. The round was led by Andreessen Horowitz, with participation from a select sy... |
| Oct 19, 2020 | AI drug-discovery firm lands first partnership | Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| May 11, 2020 | Dyno Therapeutics Raises $9M in Seed Financing | Dyno Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company applying artificial intelligence (AI) to gene therapy, raised $9m in not previously announced seed financing round. The round – secured when Dyno spun out of the lab of... |
| AI drug-discovery firm lands first partnership | Roche Group subsidiary Genentech has tapped a startup drug-discovery firm to find potential drug candidates for a variety of diseases. The deal with Genesis Therapeutics includes an upfront payment and a series of milestone payments as well... |
Reviews 0
FAQ about Dyno Therapeutics
When was Dyno Therapeutics founded?
Dyno Therapeutics was founded in 2018.
How much funding has Dyno Therapeutics raised?
Dyno Therapeutics has raised $109M in total across 2 funding rounds.
What funding rounds has Dyno Therapeutics raised?
Parsers VC lists 2 funding rounds of Dyno Therapeutics, among them a seed round of $9M on May 11, 2020.
Who has invested in Dyno Therapeutics?
Parsers VC lists 4 investors of Dyno Therapeutics, among them GV, Lux Capital Management and Sahsen Ventures.
What has the press written about Dyno Therapeutics?
Parsers VC has collected 10 articles mentioning Dyno Therapeutics, among them “ZAKA VC Backs Nephrogen’s Kidney-Focused Gene Therapy Platform” (Nov 28, 2025) and “Dyno Therapeutics Launches the Dyno bCap 1 Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence” (May 22, 2023).
Is Dyno Therapeutics still active?
Yes, Dyno Therapeutics is active; its latest activity on Parsers VC dates from Aug 18, 2026.